1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Oui Therapeutics, Inc.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2017

Location

New Haven CT US

Primary Industry

Healthcare

About

Based in Connecticut, US, and founded in 2017, Oui Therapeutics, Inc. operates as a provider of a digital therapy platform. In August 2022, the firm raised USD 11 million in series A funding co-led by investors Athyrium Capital Management, CVS Health Ventures, and Otsuka Pharmaceutical Co., Ltd. The business provides a digital therapy platform with a focus on mental health businesses, suicide prevention, and delivery paradigms for both private and public use.
Current Investors
Flare Capital Partners, First Round Capital, Athyrium Capital Management

Request a demo to show more

Primary Industry
Healthcare
Sub Industries
Healthcare, Therapeutic Devices, Application Integration Software, Medical Software
Website
www.ouitherapeutics.com
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.